NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Prescribing
  • Key to symbols

Search results for: LENALIDOMIDE


8.2.4 Other immunomodulating drugs

Total Formulary
LENALIDOMIDE (Revlimid)

Restrictions:

Formulary indications and restrictions on use are detailed in the Prescribing Notes below.

Prescribing Notes:

Muliple myeloma

  • Use for the third line treatment of multiple myeloma in combination with dexamethasone, or for patients who have received at least one prior therapy, is restricted in accordance with regional protocol
  • Adult patients with reviously untreated multiple myeloma who are not eligible for transplant. It is restricted to specialist use in accordance with regional protocol (in development) for use in patients unsuitable for thalidomide-containing regimens.

Transfusion-dependent anaemia

Use for the treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate is restricted in accordance with regional protocol.

 

Non-formulary indications:

  • Treatment of adult patients with relapsed or refractory mantle cell lymphoma is not recommended by SMC and remains non-formulary.
  • Monotherapy for the maintenance treatment of adults with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation is not recommeded by SMC and remains non-formulary.

BNF Link: https://www.medicinescomplete.com/#/content/bnf/_601622646

View this Search Result »